Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction with Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment.
| Autor: | IsHak WW; Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center Los Angeles, California 90048, USA; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Vilhauer J; Department of Psychiatry, Emory University School of Medicine, Atlanta, Georgia, USA., Kwock R; School of Public Health, University of California Los Angeles, Los Angeles, California, USA., Wu F; School of Public Health, University of California Los Angeles, Los Angeles, California, USA., Gohar S; University of California Davis Law School, Davis, California, USA., Collison K; Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center Los Angeles, California 90048, USA., Thomas SN; Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center Los Angeles, California 90048, USA., Naghdechi L; Western University of Health Sciences, College of Osteopathic Medicine, Pomona, California, USA., Elashoff D; School of Public Health, University of California Los Angeles, Los Angeles, California, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International neuropsychiatric disease journal [Int Neuropsychiatr Dis J] 2016; Vol. 7 (2). Date of Electronic Publication: 2016 May 09. |
| DOI: | 10.9734/INDJ/2016/26203 |
| Abstrakt: | Aims: This analysis aims at examining if patient-reported variables such as hope for improvement and patient satisfaction with clinician/treatment could influence the outcome major depressive disorder (MDD) treatment, namely depression remission, in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial. Study Design: Retrospective cohort study. Place and Duration of Study: The STAR*D study was conducted at 18 primary care and 23 psychiatric care settings in the United States from 2001-2007 and was funded by the National Institute of Mental health (NIMH). The analysis contained in this manuscript was conceptualized at the Cedars-Sinai Department of Psychiatry and Behavioral Neurosciences and performed at the UCLA School of Public Health. Methodology: Using data from STAR*D, the current study used logistic regression and survival analyses to examine the relationship between depressive symptoms remission and two sets of self-reported factors: Hope for improvement and, Patient satisfaction with treatment/clinician. Results: First, more than 90% of STAR*D patients reported having high hope for improvement (agree or strongly agree) and more than 66% endorsed high satisfaction with clinicians and more than 50% expressed high satisfaction with treatments (very or mostly satisfied). Second, hope for improvement was predictive of depression remission (p<0.05). Third, satisfaction with clinician/treatment, did not predict remission. Conclusion: This study shows the impact that patients' subjective hope for improvement can have on predicting depression remission in contrast to satisfaction with clinician/treatment. Future studies should prospectively incorporate patients' subjective attitudes regarding hope for improvement and satisfaction with clinicians and treatments as mediators and moderators of MDD treatment success. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|